Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no ...
NKGen Biotech, Inc., a clinical-stage biotechnology company, has announced the administration of troculeucel, an expanded autologous natural killer (NK) cell therapy, to a patient with frontotemporal ...
ZyVersa Therapeutics, Inc. has announced the FDA-authorized Emergency Compassionate Use of its investigational drug VAR 200 for a patient with ApoCII amyloidosis, a rare kidney disease characterized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results